Retina

Protein associated with deposition of mineralized calcium in tooth enamel

April 29th 2020

Discovery of protein in eye link to therapeutic options for dry AMD

April 21st 2020

Blockchain technology aims to drive big data to ‘train’ AI

April 17th 2020

Overcoming blindness: Forging a path through research

April 13th 2020

Technology 'perfect' for pediatric neuro-ophthalmology diagnoses

CME Content

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

Solange Peters, MD, PhD; Benjamin P. Levy, MD; Tony S.K. Mok, MD, BMSc, FRCP(C), FRCP(Edin), FHKCP, FHKAM(Medicine), FASCO; Maurice Pérol, MD

PER Global Perspectives: Differentiating and Managing Toxicities with TROP2-Targeted ADCs in NSCLC Through Multidisciplinary Pathways

Solange Peters, MD, PhD; Stephanie McDonald, FNP-BC, AOCNP; Antonio Passaro, MD, PhD; Jacob Sands, MD

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

SriniVas Sadda, MD, FARVO; Nathan Steinle, MD

Interventional Dry Eye: A Stepwise Treatment & Management Approach

Mark Schaeffer, OD, FAAO; Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO, FAAOMS; Selina R. McGee, OD, FAAO

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Mark R. Barakat, MD, FASRS; David Eichenbaum, MD, FASRS

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

Ramiro Maldonado, MD; Rebecca Nelson, MS, CGC; Robert A. Sisk, MD, FACS, FASRS

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

Dante Pieramici, MD, FASRS; Dean Eliott, MD; Robin A. Vora, MD; Charles C. Wykoff, MD, PhD, FASRS

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

Dilsher Dhoot, MD, FASRS; Jordana G. Fein, MD, MS; Deep Parikh, MD; Xiao-Yi (Ellie) Zhou, MD

In-Person + Virtual Event

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

David Almeida, MD, PhD, MBA; Margaret A. Chang, MD, MS; Arshad M. Khanani, MD, MA, FASRS; Jessica Randolph, MD

AREDS3 and Beyond: The Scientific Basis for B Vitamin Nutritional Supplementation in AMD

September 13, 2026

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

SriniVas R. Sadda, MD, FARVO; Mark R. Barakat, MD, FASRS; David A. Eichenbaum, MD, FASRS

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Stephen C. Pflugfelder, MD; Cecelia Koetting, OD, FAAO, DipABO

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Basil Williams, MD; Maura Di Nicola, MD

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

John Kitchens, MD; Michael W. Stewart, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Dilsher S. Dhoot, MD, FASRS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

Treating age-related macular degeneration (AMD) with eye injections

DARPin molecule reducing wet AMD treatment burden for patients

March 31st 2020

Risuteganib: Exploring novel dry AMD treatment

March 27th 2020

Fluorescein angiography key in diagnosing retinal diseases

ByMathew W. MacCumber, MD, PhD

March 26th 2020

Study shows similarity in anti-VEGF injection intervals for wet AMD

March 25th 2020

Care delivery: Motivating patients with mobile devices

March 4th 2020

If medications fail, surgery option for treating infectious retinitis

ByCheryl Guttman Krader, BS, Pharm

February 28th 2020

Bioengineering puts focus on retinal degeneration

February 21st 2020

Gene therapy offers treatment for X-linked retinitis pigmentosa

February 13th 2020

Blazing a new trail in gene therapy for retinal disease

February 12th 2020

Improving DR outcomes through comprehensive medical management

ByMark Ruchman, MD

January 30th 2020

UCLA Health neurosurgeon Nader Pouratian, MD, PhD

Prosthesis system may help blind patients 'see' again

January 23rd 2020

AI screening: Allowing physicians to see eyes more clearly from afar

January 20th 2020

New vitreoretinal tools advancing surgical outcomes

January 10th 2020

Glaucoma mystery: Focus on deep optic nerve structures

January 9th 2020

Optical coherence tomography (OCT) imaging of the macula for glaucoma detection

Macular OCT: A must for treating glaucoma patients

January 8th 2020

Brolucizumab: Less frequent dosing/maintenance of robust visual gains in wet AMD

January 7th 2020

DAVS viewing system yields increased sense of situational awareness

ByCheryl Guttman Krader, BS, Pharm

December 27th 2019

OCT data useful in hands of anterior segment specialties

December 26th 2019

Cohort 5: Injections Pre and Post RGX-314 (n=12)

Study targets subretinal option for AMD treatment

December 24th 2019

Small changes can help beat endophthalmitis bug

December 10th 2019

Research targets precision dosing for gene, cell therapy

December 4th 2019

Anti-VEGF injections and glaucoma: Surgeons must watch IOP elevation

ByLouise Gagnon

November 26th 2019

Surgeon provides pearls for handling retinal tears

November 22nd 2019

LBS-008 (Belite Bio) is a nonretinoid antagonist of retinal binding protein 4

Oral therapy targets Stargardt, dry AMD